The multifaceted cardiac sodium channel and its clinical implications

Heart

Volumn 98, Issue 17, 2012, Pages 1318-1324

  Chockalingam, Priya ^a   Wilde, Arthur ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

SODIUM CHANNEL;

CARDIAC CHANNELOPATHY; CARDIAC IMAGING; CLINICAL FEATURE; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; GENETIC COUNSELING; HEART MUSCLE CONDUCTION DISTURBANCE; HUMAN; LONG QT SYNDROME; LOSS OF FUNCTION MUTATION; MOLECULAR PATHOLOGY; MUTATIONAL ANALYSIS; MUTATOR GENE; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; RISK ASSESSMENT; SODIUM CHANNEL GENE; SODIUM CHANNELOPATHY; SODIUM CURRENT; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS; SUDDEN INFANT DEATH SYNDROME; TREATMENT PLANNING;

CHANNELOPATHIES; DEATH, SUDDEN; ELECTROCARDIOGRAPHY; GENETIC TESTING; HEART DISEASES; HUMANS; INFANT; MUTATION; NAV1.5 VOLTAGE-GATED SODIUM CHANNEL; RISK ASSESSMENT; SUDDEN INFANT DEATH; VOLTAGE-GATED SODIUM CHANNELS;

EID: 84864883258     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/heartjnl-2012-301784     Document Type: Review

References (22)

1. Anon. Survivors of out-of-hospital cardiac arrest with apparently normal heart. Need for definition and standardized clinical evaluation. Consensus statement of the Joint Steering Committees of the Unexplained Cardiac Arrest Registry of Europe and of the Idiopathic Ventricular Fibrillation Registry of the United States. Circulation 1997;95:265-72.
2. Schwartz PJ, Stramba-Badiale M, Segantini A, et al. Prolongation of the QT interval and the sudden infant death syndrome. N Engl J Med 1998;338:1709-14. First prospective study establishing a link between cardiac channelopathies and sudden infant death syndrome. (Pubitemid 28268586)
3. Chugh SS, Senashova O, Watts A, et al. Postmortem molecular screening in unexplained sudden death. J Am Coll Cardiol 2004;43:1625-9. Comprehensive research article evaluating the role of genetics in postmortem work-up of sudden cardiac death. (Pubitemid 38561345)
4. Ackerman MJ, Priori SG, Willems S, et al. HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies: this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA). Europace 2011;13:1077-109.
5. Klaver EC, Versluijs GM, Wilders R. Cardiac ion channel mutations in the sudden infant death syndrome. Int J Cardiol 2011;152:162-70. Comprehensive review of the role of cardiac channelopathies in sudden infant death syndrome.
6. Wilde AA, Brugada R. Phenotypical manifestations of mutations in the genes encoding subunits of the cardiac sodium channel. Circ Res 2011;108:884-97.
7. Wang Q, Li Z, Shen J, et al. Genomic organization of the human SCN5A gene encoding the cardiac sodium channel. Genomics 1996;34:9-16. Complete genomic characterization of the SCN5A gene.
8. Abriel H. Cardiac sodium channel Na(v)1.5 and interacting proteins: physiology and pathophysiology. J Mol Cell Cardiol 2010;48:2-11.
9. Brugada P, Brugada J. Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. A multicenter report. J Am Coll Cardiol 1992;20:1391-6. First report and description of the Brugada syndrome.
10. Chen Q, Kirsch GE, Zhang D, et al. Genetic basis and molecular mechanism for idiopathic ventricular fibrillation. Nature 1998;392:293-6. Earliest identification of the genetic basis of the Brugada syndrome. (Pubitemid 28155103)
11. Kapplinger JD, Tester DJ, Alders M, et al . An international compendium of mutations in the SCN5A-encoded cardiac sodium channel in patients referred for Brugada syndrome genetic testing. Heart Rhythm 2010;7:33-46.
12. Smits JP, Eckardt L, Probst V, et al. Genotype-phenotype relationship in Brugada syndrome: electrocardiographic features differentiate SCN5A-related patients from non-SCN5A-related patients. J Am Coll Cardiol 2002;40:350-6. (Pubitemid 34756299)
13. Kanter RJ, Pfeiffer R, Hu D, et al. Brugada-like syndrome in infancy presenting with rapid ventricular tachycardia and intraventricular conduction delay. Circulation 2012;125:14-22.
14. Schott JJ, Alshinawi C, Kyndt F, et al. Cardiac conduction defects associate with mutations in SCN5A. Nat Genet 1999;23:20-1.
15. McNair WP, Ku L, Taylor MR, et al. SCN5A mutation associated with dilated cardiomyopathy, conduction disorder, and arrhythmia. Circulation 2004;110:2163-7. (Pubitemid 39372495)
16. Benson DW, Wang DW, Dyment M, et al. Congenital sick sinus syndrome caused by recessive mutations in the cardiac sodium channel gene (SCN5A). J Clin Invest 2003;112:1019-28. (Pubitemid 38056317)
17. Darbar D, Kannankeril PJ, Donahue BS, et al . Cardiac sodium channel (SCN5A) variants associated with atrial fibrillation. Circulation 2008;117:1927-35. (Pubitemid 351543468)
18. Meregalli PG, Tan HL, Probst V, et al. Type of SCN5A mutation determines clinical severity and degree of conduction slowing in loss-of-function sodium channelopathies. Heart Rhythm 2009;6:341-8. Report on the role of genetic data in risk stratification of loss-of-function sodium channelopathies.
19. Priori SG, Schwartz PJ, Napolitano C, et al. Risk stratification in the long-QT syndrome. N Engl J Med 2003;348:1866-74. (Pubitemid 36532312)
20. Hofman N, Tan HL, Alders M, et al. Active cascade screening in primary inherited arrhythmia syndromes: does it lead to prophylactic treatment? J Am Coll Cardiol 2010;55:2570-6.
21. Schwartz PJ, Spazzolini C, Priori SG, et al. Who are the long-QT syndrome patients who receive an implantable cardioverter-defibrillator and what happens to them?: data from the European Long-QT Syndrome Implantable Cardioverter-Defibrillator (LQTS ICD) Registry. Circulation 2010;122:1272-82.
22. Belhassen B, Glick A, Viskin S. Efficacy of quinidine in high-risk patients with Brugada syndrome. Circulation 2004;110:1731-7. (Pubitemid 39299213)